Forte Biosciences Inc (FBRX)
0.6962
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 16:00
0.6962
0.00 (0.00%)
After-Hours: 20:00
Forte Biosciences Price to Book Value: 0.7175 for March 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 27, 2024 | 0.7162 |
March 26, 2024 | 0.7314 |
March 25, 2024 | 0.7317 |
March 22, 2024 | 0.7218 |
March 21, 2024 | 0.7111 |
March 20, 2024 | 0.7208 |
March 19, 2024 | 0.6802 |
March 18, 2024 | 0.6629 |
March 15, 2024 | 0.639 |
March 14, 2024 | 0.6689 |
March 13, 2024 | 0.6678 |
March 12, 2024 | 0.6926 |
March 11, 2024 | 0.7307 |
March 08, 2024 | 0.779 |
March 07, 2024 | 0.7917 |
March 06, 2024 | 0.7614 |
March 05, 2024 | 0.7336 |
March 04, 2024 | 0.7102 |
March 01, 2024 | 0.7445 |
February 29, 2024 | 0.7025 |
February 28, 2024 | 0.7408 |
February 27, 2024 | 0.705 |
February 26, 2024 | 0.711 |
February 23, 2024 | 0.71 |
February 22, 2024 | 0.6801 |
Date | Value |
---|---|
February 21, 2024 | 0.7062 |
February 20, 2024 | 0.7202 |
February 16, 2024 | 0.7105 |
February 15, 2024 | 0.7155 |
February 14, 2024 | 0.71 |
February 13, 2024 | 0.6797 |
February 12, 2024 | 0.7038 |
February 09, 2024 | 0.6482 |
February 08, 2024 | 0.6432 |
February 07, 2024 | 0.6017 |
February 06, 2024 | 0.6073 |
February 05, 2024 | 0.4976 |
February 02, 2024 | 0.605 |
February 01, 2024 | 0.6099 |
January 31, 2024 | 0.6277 |
January 30, 2024 | 0.71 |
January 29, 2024 | 0.7306 |
January 26, 2024 | 0.7689 |
January 25, 2024 | 0.6997 |
January 24, 2024 | 0.7192 |
January 23, 2024 | 0.71 |
January 22, 2024 | 0.7089 |
January 19, 2024 | 0.7169 |
January 18, 2024 | 0.7157 |
January 17, 2024 | 0.7641 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3418
Minimum
Nov 15 2023
26.78
Maximum
Sep 30 2020
4.272
Average
0.72
Median
Dec 14 2021
Price to Book Value Benchmarks
CEL-SCI Corp | 8.107 |
AIM ImmunoTech Inc | 1.065 |
IGC Pharma Inc | 2.896 |
NovaBay Pharmaceuticals Inc | 0.1350 |
Protalix BioTherapeutics Inc | 2.753 |
Price to Book Value Related Metrics
Price | 0.6962 |
Earnings Yield | -149.4% |
Market Cap | 25.34M |